Full Text View
Tabular View
No Study Results Posted
Related Studies
BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
This study has been withdrawn prior to recruitment.
Study NCT00040989   Information provided by National Cancer Institute (NCI)
First Received: July 8, 2002   Last Updated: January 11, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stage IV Renal Cell Cancer
Recurrent Renal Cell Cancer
Additional conditions recognized in this trial
Carcinoma, Renal Cell
Recurrence
More general conditions related to this trial
Adenocarcinoma
Carcinoma
Disease Attributes
Kidney Diseases
Kidney Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Pathologic Processes
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
BAY 56-3722
enzyme inhibitor therapy
Additional drug interventions recognized in this trial
Enzyme Inhibitors
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services